Most-Downgraded StocksMost-DowngradedNYSE:BSX Boston Scientific (BSX) Stock Price, News & Analysis $57.71 -0.07 (-0.11%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$57.52 -0.19 (-0.33%) As of 05/22/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Boston Scientific Stock (NYSE:BSX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Boston Scientific alerts:Sign Up Key Stats Today's Range$57.39▼$58.5150-Day Range$52.67▼$71.2952-Week Range$52.52▼$109.50Volume11.74 million shsAverage Volume17.85 million shsMarket Capitalization$85.77 billionP/E Ratio24.15Dividend YieldN/APrice Target$92.71Consensus RatingModerate Buy Company Overview Boston Scientific Corporation (NYSE: BSX) is a global medical device company that develops, manufactures and markets a broad portfolio of products used in less-invasive medical procedures. Founded in 1979 by John Abele and Peter Nicholas, the company is headquartered in Marlborough, Massachusetts, and focuses on technologies that enable physicians to treat a wide range of cardiovascular, digestive, urologic, pulmonary and chronic pain conditions without open surgery. Boston Scientific’s activities span product development, clinical research, regulatory affairs and commercial sales. Its product categories include devices and systems for interventional cardiology and peripheral interventions, electrophysiology and rhythm-management therapies, endoscopy and digestive health, as well as solutions for urology and pelvic health and neuromodulation for pain management. The company emphasizes catheter-based, implantable and endoscopic technologies designed to improve patient outcomes and reduce recovery times. The company operates and sells products globally, serving hospitals, health systems and physician practices across North America, Europe, Asia-Pacific and other international markets. Boston Scientific maintains research and development and manufacturing capabilities in multiple countries and routinely engages in clinical trials and partnerships with medical centers and physicians to support product adoption and regulatory approvals. As a publicly traded company, Boston Scientific is governed by an executive management team and board of directors that pursue a strategy combining internal innovation, clinical evidence generation and selective acquisitions to expand its product portfolio. The company continues to prioritize investment in R&D and collaboration with the medical community to advance minimally invasive treatment options. AI Generated. May Contain Errors. Read More Boston Scientific Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks95th Percentile Overall ScoreBSX MarketRank™: Boston Scientific scored higher than 95% of companies evaluated by MarketBeat, and ranked 29th out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.5 / 5Analyst RatingModerate Buy Consensus RatingBoston Scientific has received a consensus rating of Moderate Buy. The company's average rating score is 2.93, and is based on 1 strong buy rating, 23 buy ratings, 3 hold ratings, and no sell ratings.Upside PotentialBoston Scientific has a consensus price target of $92.71, representing about 60.6% upside from its current price of $57.71.Amount of Analyst CoverageBoston Scientific has been the subject of 19 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Boston Scientific's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth10.95% Earnings GrowthEarnings for Boston Scientific are expected to grow by 10.95% in the coming year, from $3.38 to $3.75 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Boston Scientific is 24.15, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.78.Price to Earnings Ratio vs. SectorThe P/E ratio of Boston Scientific is 24.15, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 21.00.Price to Earnings Growth RatioBoston Scientific has a PEG Ratio of 1.06. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioBoston Scientific has a P/B Ratio of 3.28. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Boston Scientific's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.93% of the float of Boston Scientific has been sold short.Short Interest Ratio / Days to CoverBoston Scientific has a short interest ratio ("days to cover") of 1.36, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Boston Scientific has recently increased by 11.82%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBoston Scientific does not currently pay a dividend.Dividend GrowthBoston Scientific does not have a long track record of dividend growth. News and Social Media4.3 / 5News Sentiment0.95 News SentimentBoston Scientific has a news sentiment score of 0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.45 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 64 news articles for Boston Scientific this week, compared to 12 articles on an average week.Search Interest95 people have searched for BSX on MarketBeat in the last 30 days. This is an increase of 8% compared to the previous 30 days.MarketBeat Follows18 people have added Boston Scientific to their MarketBeat watchlist in the last 30 days. This is an increase of 6% compared to the previous 30 days. Company Ownership2.9 / 5Insider TradingAcquiring Shares Cluster Insider Buying3 insiders have purchased shares of Boston Scientific in the last three months. Multiple insiders buying is a strong bullish signal.Insider Buying vs. Insider SellingIn the past three months, Boston Scientific insiders have bought more of their company's stock than they have sold. Specifically, they have bought $554,012.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders0.34% of the stock of Boston Scientific is held by insiders.Percentage Held by Institutions89.07% of the stock of Boston Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Boston Scientific's insider trading history. Receive BSX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Boston Scientific and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BSX Stock News HeadlinesNotable healthcare headlines for the week: UnitedHealth, Boston Scientific, and Eli Lilly in focusMay 24 at 10:31 AM | seekingalpha.comThis Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34%May 23 at 7:14 PM | fool.comLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.May 25 at 1:00 AM | InvestorPlace (Ad)What to Know About This Fund's $10 Million Nektar Bet Ahead of a Key Phase 3 LaunchMay 23 at 7:14 PM | fool.comWhy Is Boston Scientific (BSX) Down 13% Since Last Earnings Report?May 22 at 12:52 PM | finance.yahoo.comBoston Scientific (NYSE:BSX) Director Cheryl Pegus Purchases 1,770 SharesMay 22 at 8:17 AM | insidertrades.comBelo Sun Provides Update on Ongoing Proceedings Before TRF-1May 21, 2026 | globenewswire.comBoston Scientific Trial Success Adds Weight To SEISMIQ 4CE And BSX ValuationMay 20, 2026 | finance.yahoo.comSee More Headlines BSX Stock Analysis - Frequently Asked Questions How have BSX shares performed this year? Boston Scientific's stock was trading at $95.29 on January 1st, 2026. Since then, BSX shares have decreased by 39.4% and is now trading at $57.7140. How were Boston Scientific's earnings last quarter? Boston Scientific Corporation (NYSE:BSX) posted its quarterly earnings results on Wednesday, April, 22nd. The medical equipment provider reported $0.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.79 by $0.01. The firm's revenue was up 11.6% on a year-over-year basis. Read the conference call transcript. Is Boston Scientific buying back stock? Boston Scientific's board authorized a stock repurchase plan on Monday, May 18th 2026, which authorizes the company to buy back $5,000,000,000 in outstanding shares, according to EventVestor. This means that the company could purchase up to 6.4% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company's leadership believes its shares are undervalued. Does Boston Scientific have any subsidiaries? The following companies are subsidiaries of Boston Scientific: VertiFlex, BTG, Augmenix, Veniti, Claret Medical, Cryterion Medical, nVision Medical, and others. Who are Boston Scientific's major shareholders? Boston Scientific's top institutional investors include Bank of America Corp DE (1.53%), Bollard Group LLC (1.25%), Janus Henderson Group PLC (1.11%) and Amundi (0.95%). Insiders that own company stock include Michael F Mahoney, Daniel J Brennan, Joseph Michael Fitzgerald, Vance R Brown, Eric Francis Yves Thepaut, Wendy Carruthers, Jeffrey B Mirviss, Edward J Ludwig, Edward J Ludwig, Ellen M Zane, Arthur C Butcher, John Bradley Sorenson, Yoshiaki Fujimori, Cheryl Pegus and Charles J Dockendorff. View institutional ownership trends. How do I buy shares of Boston Scientific? Shares of BSX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Boston Scientific own? Based on aggregate information from My MarketBeat watchlists, some other companies that Boston Scientific investors own include BlackRock (BLK), Broadcom (AVGO), ServiceNow (NOW), UnitedHealth Group (UNH), The Goldman Sachs Group (GS), NVIDIA (NVDA) and Illinois Tool Works (ITW). Company Calendar Last Earnings4/22/2026Today5/25/2026Bernstein 42nd Annual Strategic Decisions Conference5/27/2026Next Earnings (Estimated)7/29/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (5m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 BSX's financial health is in the Red zone, according to TradeSmith. BSX has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED PRODUCTS Sub-IndustryHealth Care Equipment Current SymbolNYSE:BSX CIK885725 Webwww.bostonscientific.com Phone(508) 683-4000Fax508-683-5675Employees59,000Year Founded1979Price Target and Rating Average Price Target for Boston Scientific$92.71 High Price Target$128.00 Low Price Target$68.00 Potential Upside/Downside+60.6%Consensus RatingModerate Buy Rating Score (0-4)2.93 Research Coverage27 Analysts Profitability EPS (Trailing Twelve Months)$2.39 Trailing P/E Ratio24.15 Forward P/E Ratio17.08 P/E Growth1.06Net Income$2.90 billion Net Margins17.29% Pretax Margin18.15% Return on Equity19.17% Return on Assets10.77% Debt Debt-to-Equity Ratio0.42 Current Ratio1.90 Quick Ratio1.22 Sales & Book Value Annual Sales$20.07 billion Price / Sales4.27 Cash Flow$4.03 per share Price / Cash Flow14.32 Book Value$17.57 per share Price / Book3.28Miscellaneous Outstanding Shares1,486,180,000Free Float1,481,122,000Market Cap$85.77 billion OptionableOptionable Beta0.62 Social Links 10 Stocks Set to Soar in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free Report This page (NYSE:BSX) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredRead now. Do not delete. You’ve been warned.Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...Porter & Company | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Boston Scientific Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Boston Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
